Science 37 (NASDAQ:SNCE – Get Rating) and Affinity Energy and Health (OTCMKTS:ALGXY – Get Rating) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, risk, earnings, analyst recommendations, dividends and institutional ownership.
Risk & Volatility
Science 37 has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, Affinity Energy and Health has a beta of 135.11, suggesting that its share price is 13,411% more volatile than the S&P 500.
Get
Science 37 alerts:
Earnings and Valuation
This table compares Science 37 and Affinity Energy and Health's top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
| Science 37 | $59.60 million | 1.41 | -$94.33 million | ($0.50) | -1.44 |
| Affinity Energy and Health | $2.05 million | N/A | -$6.08 million | N/A | N/A |
Affinity Energy and Health has lower revenue, but higher earnings than Science 37.
Insider & Institutional Ownership
58.6% of Science 37 shares are held by institutional investors. 4.4% of Science 37 shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Science 37 and Affinity Energy and Health's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
| Science 37 | -66.46% | -72.32% | -51.04% |
| Affinity Energy and Health | N/A | N/A | N/A |
Analyst Ratings
This is a breakdown of current recommendations and price targets for Science 37 and Affinity Energy and Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
| Science 37 | 0 | 1 | 4 | 0 | 2.80 |
| Affinity Energy and Health | 0 | 0 | 0 | 0 | N/A |
Science 37 currently has a consensus target price of $3.75, indicating a potential upside of 419.61%.
Summary
Affinity Energy and Health beats Science 37 on 5 of the 9 factors compared between the two stocks.
About Science 37
(Get Rating)
Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
About Affinity Energy and Health
(Get Rating)
Affinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.
Receive News & Ratings for Science 37 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Science 37 and related companies with MarketBeat.com's FREE daily email newsletter.
